Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 3

Serum albumin-corrected calcium, P, and whole-PTH levels during the denosumab treatment course.

	Baseline	1 week	1 month	value; versus
Corrected Ca (mg/dl)	9.2 ± 0.5	8.5 ± 1.1	9.2 ± 0.9
Phosphate (mg/dl)	5.0 ± 1.3	4.2 ± 0.9	4.0 ± 1.1
W-PTH (pg/dl)	164 (58.5 to 228)	224 (96 to 355.5)	161 (82.5 to 234)	NS

W-PTH: whole PTH. Median and interquartile range are shown for whole PTH.